← Back to All Stocks

Leap Therapeutics, Inc. (LPTX) Analysis

Generated on: 2025-08-20 20:11:53 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$0.27
Predicted Price
$0.31
Expected Return
12.04%
Confidence Score
0.80
RSI (14)
42.82
MACD
-0.02
Volume
1,063,775
Float Shares
32,223,378
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250

LPTX

Leap Therapeutics, Inc.
12.04%
Price: $0.27
Confidence: 0.80
News
Low Float
Last updated: 2025-08-20 20:11:53

Technical Analysis

RSI: 42.82
MACD: -0.02
Technical Analysis Graph

Risk Analysis

Volatility
120.22%
Max Drawdown
-94.71%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer
Benzinga - 2025-03-26 17:29
Leap Therapeutics, Inc. (NASDAQ:LPTX) presented updated preliminary data on Wednesday from Part B of the DeFianCe Phase 2 trial of sirexatamab (DKN-01) in combination with bevacizumab and chemotherapy (Experimental Arm) compared to bevacizumab and chemotherapy (Control Arm). The trial enrolled patients with advanced microsatellite stable (MSS) colorectal cancer (CRC) who have received one prior systemic therapy for advanced disease. The updated analysis shared on Wednesday includes the overall r

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.